Atlas Trials

Stage IV Fallopian Tube Cancer AJCC v8

19 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage IV Fallopian Tube Cancer AJCC v8

RecordFirmDate
Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax (NCT05092373)M.D. Anderson Cancer Center2022-04-29
Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer (NCT04673448)University of Washington2021-10-18
Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients (NCT05047926)Mayo Clinic2021-10-05
Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors (NCT04616534)National Cancer Institute (NCI)2021-06-01
Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer (NCT04498520)Pamela Munster2021-03-31
National Cancer Institute "Cancer Moonshot Biobank" (NCT04314401)National Cancer Institute (NCI)2020-11-11
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial (NCT04575935)M.D. Anderson Cancer Center2020-08-05
Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers (NCT03968406)M.D. Anderson Cancer Center2019-09-26
Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT04095364)NRG Oncology2019-09-20
Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery (NCT03943173)M.D. Anderson Cancer Center2019-06-07
Modified Immune Cells (Autologous CAR T Cells) in Treating Patients with Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer (NCT03907527)Precigen, Inc2019-04-30
Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1 (NCT02650986)Roswell Park Cancer Institute2017-07-14

Track Stage IV Fallopian Tube Cancer AJCC v8 automatically

Every clearance here is in the API, with alerts when new ones post.